Literature DB >> 26099528

Innovative designs of point-of-care comparative effectiveness trials.

Mei-Chiung Shih1, Mintu Turakhia2, Tze Leung Lai3.   

Abstract

One of the provisions of the health care reform legislation in 2010 was for funding pragmatic clinical trials or large observational studies for comparing the effectiveness of different approved medical treatments, involving broadly representative patient populations. After reviewing pragmatic clinical trials and the issues and challenges that have made them just a small fraction of comparative effectiveness research (CER), we focus on a recent development that uses point-of-care (POC) clinical trials to address the issue of "knowledge-action gap" in pragmatic CER trials. We give illustrative examples of POC-CER trials and describe a trial that we are currently planning to compare the effectiveness of newly approved oral anticoagulants. We also develop novel stage-wise designs of information-rich POC-CER trials under competitive budget constraints, by using recent advances in adaptive designs and other statistical methodologies. Published by Elsevier Inc.

Entities:  

Keywords:  Adaptive design; Anticoagulants; Comparative effectiveness; Point-of-care trials; Pragmatic trials; Shared decision making

Mesh:

Substances:

Year:  2015        PMID: 26099528      PMCID: PMC4639459          DOI: 10.1016/j.cct.2015.06.014

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  41 in total

1.  Nonparametric analysis of recurrent events and death.

Authors:  D Ghosh; D Y Lin
Journal:  Biometrics       Date:  2000-06       Impact factor: 2.571

2.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

3.  Random-effects Cox proportional hazards model: general variance components methods for time-to-event data.

Authors:  V Shane Pankratz; Mariza de Andrade; Terry M Therneau
Journal:  Genet Epidemiol       Date:  2005-02       Impact factor: 2.135

4.  Statistical methods for analyzing sequentially randomized trials.

Authors:  Oliver Bembom; Mark J van der Laan
Journal:  J Natl Cancer Inst       Date:  2007-10-30       Impact factor: 13.506

Review 5.  Design of clinical trials with failure-time endpoints and interim analyses: An update after fifteen years.

Authors:  Pei He; Tze Leung Lai; Zheng Su
Journal:  Contemp Clin Trials       Date:  2015-05-29       Impact factor: 2.226

6.  Implementation of the Department of Veterans Affairs' first point-of-care clinical trial.

Authors:  Leonard D'Avolio; Ryan Ferguson; Sergey Goryachev; Patricia Woods; Thomas Sabin; Joseph O'Neil; Chester Conrad; Joseph Gillon; Jasmine Escalera; Mary Brophy; Phillip Lavori; Louis Fiore
Journal:  J Am Med Inform Assoc       Date:  2012-02-24       Impact factor: 4.497

Review 7.  Shared decision making in atrial fibrillation: where we are and where we should be going.

Authors:  Luke Seaburg; Erik P Hess; Megan Coylewright; Henry H Ting; Christopher J McLeod; Victor M Montori
Journal:  Circulation       Date:  2014-02-11       Impact factor: 29.690

8.  Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.

Authors:  Peter F Thall; Christopher Logothetis; Lance C Pagliaro; Sijin Wen; Melissa A Brown; Dallas Williams; Randall E Millikan
Journal:  J Natl Cancer Inst       Date:  2007-10-30       Impact factor: 13.506

9.  Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration.

Authors:  Supriya Shore; Evan P Carey; Mintu P Turakhia; Cynthia A Jackevicius; Fran Cunningham; Louise Pilote; Steven M Bradley; Thomas M Maddox; Gary K Grunwald; Anna E Barón; John S Rumsfeld; Paul D Varosy; Preston M Schneider; Lucas N Marzec; P Michael Ho
Journal:  Am Heart J       Date:  2014-04-05       Impact factor: 4.749

10.  Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1986-07-12       Impact factor: 79.321

View more
  5 in total

1.  Patients' beliefs regarding informed consent for low-risk pragmatic trials.

Authors:  Rafael Dal-Ré; Antonio J Carcas; Xavier Carné; David Wendler
Journal:  BMC Med Res Methodol       Date:  2017-09-18       Impact factor: 4.615

2.  Opportunities and barriers for pragmatic embedded trials: Triumphs and tribulations.

Authors:  Joakim Ramsberg; Richard Platt
Journal:  Learn Health Syst       Date:  2017-11-02

3.  Online randomized controlled experiments at scale: lessons and extensions to medicine.

Authors:  Ron Kohavi; Diane Tang; Ya Xu; Lars G Hemkens; John P A Ioannidis
Journal:  Trials       Date:  2020-02-07       Impact factor: 2.279

Review 4.  Clinical research challenges posed by difficult-to-treat depression.

Authors:  A John Rush; Harold A Sackeim; Charles R Conway; Mark T Bunker; Steven D Hollon; Koen Demyttenaere; Allan H Young; Scott T Aaronson; Maxine Dibué; Michael E Thase; R Hamish McAllister-Williams
Journal:  Psychol Med       Date:  2022-01-07       Impact factor: 7.723

5.  Design and implementation of pragmatic clinical trials using the electronic medical record and an adaptive design.

Authors:  Kelly Claire Simon; Samuel Tideman; Laura Hillman; Rebekah Lai; Raman Jathar; Yuan Ji; Stuart Bergman-Bock; James Castle; Tiffani Franada; Thomas Freedom; Revital Marcus; Angela Mark; Steven Meyers; Susan Rubin; Irene Semenov; Chad Yucus; Anna Pham; Lisette Garduno; Monika Szela; Roberta Frigerio; Demetrius M Maraganore
Journal:  JAMIA Open       Date:  2018-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.